MKI67 and papilloma: The number of Ki-67-positive cells was significantly higher in papillomas of CD109+/+ mice than in those of CD109−/− mice at 17 weeks after DMBA initiation (P < 0.05; Figure 3F, Supplementary Figure S5B).